Xenetic Biosciences Inc (XBIO)
3.72
+0.17
(+4.79%)
USD |
NASDAQ |
May 17, 16:00
3.72
0.00 (0.00%)
After-Hours: 20:00
Xenetic Biosciences Net Income (Quarterly): -1.195M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -1.195M |
| December 31, 2023 | -1.172M |
| September 30, 2023 | -1.056M |
| June 30, 2023 | -1.051M |
| March 31, 2023 | -0.8566M |
| December 31, 2022 | -1.482M |
| September 30, 2022 | -0.804M |
| June 30, 2022 | -2.672M |
| March 31, 2022 | -1.594M |
| December 31, 2021 | -1.842M |
| September 30, 2021 | -1.351M |
| June 30, 2021 | -1.107M |
| March 31, 2021 | -1.346M |
| December 31, 2020 | -1.20M |
| September 30, 2020 | -7.560M |
| June 30, 2020 | -0.9536M |
| March 31, 2020 | -1.179M |
| December 31, 2019 | -1.170M |
| September 30, 2019 | -8.900M |
| June 30, 2019 | -1.377M |
| March 31, 2019 | -1.327M |
| December 31, 2018 | -1.639M |
| September 30, 2018 | -1.812M |
| June 30, 2018 | -2.026M |
| March 31, 2018 | -1.822M |
| Date | Value |
|---|---|
| December 31, 2017 | 4.445M |
| September 30, 2017 | -2.256M |
| June 30, 2017 | -2.919M |
| March 31, 2017 | -2.866M |
| December 31, 2016 | -0.3913M |
| September 30, 2016 | -2.472M |
| June 30, 2016 | -47.77M |
| March 31, 2016 | -3.572M |
| December 31, 2015 | -3.627M |
| September 30, 2015 | -5.324M |
| June 30, 2015 | -1.125M |
| March 31, 2015 | -2.431M |
| December 31, 2014 | -4.303M |
| September 30, 2014 | -3.182M |
| June 30, 2014 | -2.759M |
| March 31, 2014 | -4.063M |
| November 30, 2013 | -0.0825M |
| August 31, 2013 | -0.0761M |
| May 31, 2013 | -0.0137M |
| February 28, 2013 | 0.0151M |
| November 30, 2012 | -0.0145M |
| August 31, 2012 | -0.0434M |
| May 31, 2012 | -0.0389M |
| February 29, 2012 | -0.0293M |
| November 30, 2011 | -0.0182M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-8.900M
Minimum
Sep 2019
-0.804M
Maximum
Sep 2022
-1.993M
Average
-1.198M
Median
Net Income (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -12.28M |
| Electromed Inc | 1.493M |
| Xtant Medical Holdings Inc | -4.40M |
| Asensus Surgical Inc | -22.50M |
| Myomo Inc | -3.836M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.5108M |
| Total Expenses (Quarterly) | 1.779M |
| EPS Diluted (Quarterly) | -0.78 |
| Enterprise Value | -2.263M |
| Profit Margin (Quarterly) | -234.0% |
| Earnings Yield | -81.21% |
| Normalized Earnings Yield | -81.21 |